Novartis AG
NVSEF | OTC
$138.38
+$0.13 (+0.09%)
At close: Sep 22, 2026, 4:00 PM ET
$138.38
$0 (0.00%)
After-hours:
Sep 23, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 | Q4 2020 Dec 30, 2020 | Q3 2020 Sep 29, 2020 | Q2 2020 Jun 29, 2020 | Q1 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 4.02B | 3.61B | 2.82B | 3.26B | 3.27B | 2.61B | 2.64B | 1.51B | 2.32B | 2.29B | 1.47B | 1.58B | 1.7B | 2.22B | 16.31B | 2.76B | 2.9B | 2.06B | 2.1B | 1.93B | 1.87B | 2.17B |
Depreciation & Amortization | 1.26B | 1.15B | 1.63B | 2.01B | 1.17B | 1.27B | 1.59B | 3.11B | 1.83B | 2B | 1.95B | 2.03B | 1.8B | 1.41B | 1.52B | 1.45B | 1.44B | 1.7B | 1.62B | 1.73B | 1.7B | 1.41B |
Stock-Based Compensation | 267M | 262M | 272M | 255M | 257M | 260M | 248M | 205M | 222M | 190M | 197M | 219M | 204M | 203M | 195M | 173M | 185M | 183M | 159M | 202M | 199M | 178M |
Other Working Capital | 796M | -617.43M | -543M | 723.94M | 589.73M | -848.07M | -741M | 1.51B | 512M | -121M | -51M | 920M | -54M | -2.01B | 1.18B | 409M | 130M | -1.47B | 1.22B | -36M | 650M | -2.13B |
Other Non-Cash Items | 168M | -382.58M | -997M | -478.7M | 3.53B | 4.54B | -1.28B | -668M | -1.09B | -474M | -360M | 80M | -239M | -617M | -15.96B | -340M | -1.13B | -726M | -1.55B | -1.15B | -879M | 446M |
Deferred Income Tax | 507M | 798M | 465M | 200M | 595M | 441M | -261M | 39M | 452M | 446M | 275M | 344M | 347M | 450M | 645M | 472M | 611M | 391M | 460M | 478M | 421M | 448M |
Change in Working Capital | 442M | -1.8B | 5M | 1.04B | -89.17M | -2.26B | -384M | 1.18B | -162M | -1.5B | 585M | 477M | -54M | -2.01B | 1.18B | 409M | 130M | -1.47B | 1.22B | -36M | 650M | -2.13B |
Operating Cash Flow | 6.66B | 3.65B | 4.19B | 6.29B | 4.86B | 2.2B | 2.55B | 5.38B | 3.58B | 2.96B | 4.11B | 4.72B | 3.76B | 1.65B | 3.88B | 4.93B | 4.13B | 2.13B | 4.01B | 3.16B | 3.96B | 2.53B |
Capital Expenditures | -558M | -254M | -1.13B | -799M | -740.08M | -1.12B | -783M | -683M | -996M | -470M | -647M | -582M | -583M | -859M | -977M | -539M | -597M | -858M | -1.02B | -627M | -452M | -480M |
Cash Acquisitions | -1.68B | -7M | -264M | -12.1M | -3.25B | -269.44M | -11M | -3.45B | -86M | -42M | -11M | 8M | -61M | -839M | 20.33B | -17M | -2M | -211M | 53M | -112M | -2M | -9.9B |
Purchase of Investments | -58M | -55M | -2.31B | -1.01B | -279.91M | -48.46M | -573M | -39M | -31M | -107M | -10.58B | -6.71B | -13.27B | -4.26B | -15.63B | -807M | -87M | -86M | -160M | -1.54B | -112M | -323M |
Sales Maturities Of Investments | 50M | 1.91B | 581M | 1.51B | 1.06B | 566.99M | 179M | 290M | 50M | 11.08B | 9.66B | 12.46B | 2.15B | 15.22B | 689M | 22M | 246M | 1.8B | 308M | 154M | 189M | 564M |
Other Investing Acitivies | -226M | 4.08M | -487M | -538.24M | 19.79M | -431M | -572M | 1.67B | 10M | 162M | 108M | 21M | 140M | 99M | -364M | -79M | 261M | -480M | -251M | -273M | -262M | -245M |
Investing Cash Flow | -2.24B | 330M | -3.03B | -374M | -3.19B | -871.33M | -1.76B | -2.21B | -1.05B | 10.62B | -1.47B | 5.2B | -11.63B | 9.37B | 4.56B | -1.23B | 97M | 780M | -571M | -2.05B | -425M | -10.14B |
Debt Repayment | 181M | -461.04M | -106M | 2.51B | 833M | 1.15B | 610M | -2.29B | -737.17M | 933M | -1.25B | -1.87B | n/a | 404M | -738M | -1.15B | -78M | 755M | -96M | 2.82B | -2.25B | 7.53B |
Common Stock Repurchased | -2.71B | -2.72B | -2.76B | -2.85B | -1.62B | -1.1B | -1.25B | -1.63B | -2.96B | -2.89B | -2.68B | -2.72B | -2.71B | -2.54B | -148M | -284M | -703M | -1.92B | -1.77B | -924M | -9M | -141M |
Dividend Paid | -2.49B | -5.33B | -4.14M | 85.3M | -2.48B | -5.05B | -57.58M | -53.24M | -106.72M | -7.33B | -50.99M | -32.23M | -162.43M | -7.51B | -39.93M | -8.45M | -17.62M | -7.37B | n/a | n/a | n/a | -6.99B |
Other Financial Acitivies | -195M | 3.14M | -123.86M | -48.31M | -22.9M | -205.11M | 34M | 3.08B | 57.17M | 6M | 122.94M | -118.32M | 574.43M | 116M | -2.37B | -96M | -2.16B | -5M | -1.07B | 8M | 69M | 609M |
Financial Cash Flow | -5.21B | -8.55B | -3B | -382M | -3.25B | -5.01B | -607M | -832M | -3.64B | -9.2B | -3.99B | -4.74B | -2.3B | -9.53B | -3.25B | -1.53B | -2.94B | -8.54B | -2.94B | 1.9B | -2.19B | 1.01B |
Net Cash Flow | -410M | -4.39B | -2.15B | 5.71B | -1.55B | -3.93B | 988M | 1.52B | -1.12B | 4.48B | -1.21B | 5.1B | -10.23B | 1.45B | 5.2B | 2.09B | 1.32B | -5.86B | 664M | 3.08B | 1.39B | -6.58B |
Free Cash Flow | 6.11B | 3.39B | 3.06B | 5.49B | 4.12B | 1.07B | 1.76B | 4.7B | 2.58B | 2.49B | 3.46B | 4.14B | 3.17B | 790M | 2.91B | 4.39B | 3.54B | 1.27B | 2.98B | 2.53B | 3.51B | 2.05B |
Adj. Free Cash Flow | 5.84B | 3.13B | 2.79B | 5.23B | 3.87B | 814.86M | 1.52B | 4.49B | 2.36B | 2.3B | 3.27B | 3.92B | 2.97B | 587M | 2.71B | 4.21B | 3.35B | 1.09B | 2.82B | 2.33B | 3.31B | 1.87B |
Maintenance CapEx | -558M | -254M | -676.71M | -523.68M | -740.08M | -1.12B | -783M | -683M | -764.55M | -362.84M | -647M | -582M | -583M | -825.03M | -831.89M | -294.5M | -103.88M | -858M | -928.05M | -610.07M | -452M | -101.09M |
Growth CapEx | n/a | n/a | -454.29M | -275.32M | n/a | n/a | n/a | n/a | -231.45M | -107.16M | n/a | n/a | n/a | -33.97M | -145.11M | -244.5M | -493.12M | n/a | -94.95M | -16.93M | n/a | -378.91M |
Owner Earnings | 6.11B | 3.39B | 3.52B | 5.76B | 4.12B | 1.07B | 1.76B | 4.7B | 2.81B | 2.59B | 3.46B | 4.14B | 3.17B | 823.97M | 3.05B | 4.63B | 4.03B | 1.27B | 3.08B | 2.55B | 3.51B | 2.43B |
Add to Watchlist
Select watchlists to add or remove NVSEF